Aim. To date, the value of culture results after a debridement, antibiotics and implant retention (DAIR) for early (suspected) prosthetic joint infection (PJI) as risk indicators in terms of prosthesis retention is not clear. At one year follow-up, the relative risk of prosthesis removal was determined for culture-positive and culture-negative DAIRs after primary total hip or knee arthroplasty. The secondary aim was to explore differences in patient characteristics, infection characteristics and outcomes between these two groups. Methods. A retrospective regional registry study was performed in a group of 359 patients (positive cultures: n = 299, negative cultures n = 60) undergoing DAIR for high suspicion of early PJI in the period from 2014 to 2019. Differences in patient characteristics, deceased patients and number of subsequent DAIRs between the positive and negative DAIR groups were analyzed using independent t-tests, Mann-Whitney, Pearson's Chi-square tests and Fisher's Exact tests. Results. Overall implant survival rate following DAIR was 89%. The relative risk for prosthesis removal was 7.4 times higher (95% confidence interval (CI) 1.0–53.1) in the positive DAIR group (37/299, 12.4%) compared to the negative DAIR group (1/60, 1.7%). The positive group had a higher body mass index (p = 0.034), rate of wound leakage of >10 days (p = 0.016) and more subsequent DAIRs (p = 0.006). Conclusion. Since implant survival results after DAIR are favorable, the threshold to perform a DAIR procedure in early PJI should be low in order to retain the prosthesis. A DAIR procedure in case of negative cultures does not seem to have unfavorable results in terms of prosthesis retention

Purpose. Case logs have been utilized as a means of assessing residents surgical exposure and involvement in cases. It can be argued that the degree of involvement in operative cases is as important as absolute number of cases logged. A log which contains accurate information on actual participation in surgical cases in addition to self reported competency, is a powerful tool in obtaining a true reflection of surgical experience. Thus a prerequisite for a valuable log is the ability to perform an accurate self-assessment. Numerous studies have shown mixed results when examining residents ability to perform self-assessment on varying tasks. The purpose of the study was to examine the correlation between residents self-assessment and staff surgeons evaluation of surgical involvement and competence in performing primary hip and knee arthroplasty surgery. Method. Self assessment data from 65 primary hip and knee arthroplasty cases involving 17 residents and 17 staff surgeons (93% response rate) was analyzed. Interobserver agreement between residents self perception and staff surgeons assessment of involvement was evaluated using the Intraclass Correlation Coefficient (ICC). An assessment of competency was performed utilizing a categorical global scale and evaluated with the Kappa statistic (k). Furthermore, a structured surgical skills assessment form was piloted as an objective appraisal of resident involvement and comparisons were made to resident and staff perception. Results. The Intraclass Correlation Coefficient for resident involvement between Resident and Staff was 0.80 (0.69–0.88) which represents substantial agreement between the groups. The agreement between resident and staff with regard to residents competency to perform case was k = 0.67 (0.50–0.84). The ICC for Resident, Staff, and Third Party observer utilizing the piloted skills assessment form was 0.82 (0.75–0.88) which represents substantial agreement and helps to confirm the agreement between various members of the surgical team. Conclusion. This study may help to confirm the ability of orthopaedic residents to perform a self-assessment of their degree of involvement and performance competency in primary hip and knee arthroplasty surgery. Furthermore, the staff surgeons assessment of resident involvement was highly correlated with the surgical skills assessment form. The inclusion of a self-assessment is a valuable addition to the surgical case log

Aim. Reveal the rate of surgical site infection (SSI) after primary hip and knee arthroplasty in patients with inflammatory joint disease and analyse if the infection rate was correlated to the given anti-rheumatic treatment. The background is that since 2006 patients operated at the orthopaedic department at Skåne University hospital, Lund, Sweden, have continued treatment with TNF-alpha inhibitors during the perioperative period. Method. During 2006 to 2015 494 planned primary hip and knee arthroplasties were performed on 395 patients (236 hip arthroplasties and 239 knee arthroplasties). Data on age, sex, diagnosis, BMI, operation time, ASA-classification, treatment with cDMARDs (conventional disease modifying anti-rheumatic drugs) and bDMARDs (biological disease modifying antirheumatic drugs) and use of prednisolone was collected. The primary outcome variable was prosthetic joint infection (PJI) within 1 year from surgery with a secondary outcome variable being superficial SSI. Results. In 32% (n=159) of the cases the patient was treated with a TNF-alpha inhibitor. The rate of PJI was 1.4% (n=7). The overall rate of infection, including superficial infections, was 2.4% (n=12). All the PJIs occurred after a knee arthroplasty and only 1 patient was treated with a TNF-alpha inhibitor (etanercept). Conclusions. We could not find that continuing treatment with TNF-inhibitors perioperatively led to a higher incidence of PJI or SSI than generally would be expected in a group of patients with an inflammatory joint disease. Based on these results there is no need to discontinue treatment with TNF-inhibitors when performing arthroplasty surgery

Extended patient waiting lists for assessment and treatment are widely reported for planned elective joint replacement surgery. The development of regionally based Elective Orthopaedic Centres, separate from units that provide acute, urgent or trauma care has been suggested as one solution to provide protected capacity and patient pathways. These centres will adopt protocolised care to allow high volume activity and increased day-case care. We report the plan to establish a new elective orthopaedic centre serving a population of 2.4 million people. A census conducted in 2022 identified that 15000 patients were awaiting joint replacement surgery with predictions for further increases in waiting times

The principle of care will be to offer routine primary arthroplasty surgery for low risk (ASA 1 and 2) patients at a new regional centre. Pre-operative assessment and preparation will be undertaken digitally, virtually and/or in person at local centres close to the where patients live. This requires new and integrated pathways and ways of working. Predicting which patients will require perioperative transfusion of blood products is an important safety and quality consideration for new pathways. We reviewed all cases of hip and knee arthroplasty surgery conducted at our centre over a 12-month period and identified pre-operative patient related predictive factors to allow us to predict the need for the perioperative transfusion of blood products.

We examined patient sex, age, pre-operative haemaglobin and platelet count, use of anti-coagulants, weight and body mass index to allow us to construct the Imperial blood transfusion tool.

We have used the results of our study and the transfusion tool to propose the patient pathway for the new regional elective orthopaedic centre which we present.

Same day home (SDH) discharge in total joint arthroplasty (TJA) has increased in popularity in recent years. The objective of this study was to evaluate the causes and predictors of failed discharges in planned SDH patients.

A consecutive cohort of patients who underwent total knee (TKA) or total hip arthroplasty (THA) that were scheduled for SDH discharge between April 1, 2019 to March 31, 2021 were retrospectively reviewed. Patient demographics, causes of failed discharge, perioperative variables, 30-day readmissions and 6-month reoperation rates were collected. Multivariate regression analysis was undertaken to identify independent predictors of failed discharge.

The cohort consisted of 527 consecutive patients. One hundred and one (19%) patients failed SDH discharge. The leading causes were postoperative hypotension (20%) and patients who were ineligible for the SDH pathway (19%). Two individual surgeons, later operative start time (OR 1.3, 95% CI, 1.15-1.55, p=0.001), ASA class IV (OR 3.4, 95% CI, 1.4-8.2; p=0.006) and undergoing a THA (OR 2.0, 95% CI, 1.2-3.1, p=0.004) were independent predictors of failed SDH discharge. No differences in age, BMI, gender, surgical approach or type of anesthetic were found (p>0.05). The 30-day readmission or 6-month reoperation were similar between groups (p>0.05).

Hypotension and inappropriate patient selection were the leading causes of failed SDH discharge. Significant variability existed between individual surgeons failed discharge rates. Patients undergoing a THA, classified as ASA IV or had a later operative start time were all more likely to fail SDH discharge.

Arthroplasty procedures in low-income countries are mostly performed at tertiary centers, with waiting lists exceeding 12 to 24 months. Providing arthroplasty services at other levels of healthcare aims to offset this burden, however there is a marked paucity of literature regarding surgical outcomes. This study aims to provide evidence on the safety of arthroplasty at district level.

Retrospective review of consecutive arthroplasty cases performed at a District Hospital (DH), and a Tertiary Hospital (TH) in Cape Town, between January 2015 and December 2018. Patient demographics, hospital length of stay, surgery related readmissions, reoperations, post-operative complications, and mortality rates were compared between cohorts.

Seven hundred and ninety-five primary arthroplasty surgeries were performed at TH level and 228 at DH level. The average hospital stay was 5.2±2.0 days at DH level and 7.6±7.1 days for TH (p<0.05). Readmissions within 3 months post-surgery of 1.75% (4 patients) for district and 4.40% (35) for TH (p<0.05). Reoperation rate of 1 in every 100 patients at the DH and 8.3 in every 100 patients at the TH (p<0.05). Death rate was 0.4% vs 0.6% at district and TH respectively (p>0.05). Periprosthetic joint infection rate was 0.43% at DH and 2.26% at TH. The percentage of hip dislocation requiring revision was 0% at district and 0.37% at TH. During the study period, 228 patients received arthroplasty surgery at the DH; these patients would otherwise have remained on the TH waiting list.

Hip and Knee Arthroplasty at District health care level is safe and may help ease the burden on arthroplasty services at tertiary care facilities in a Southern African context. Adequately trained surgeons should be encouraged to perform these procedures in district hospitals provided there is appropriate patient selection and adherence to strict theatre operating procedures.

Introduction. Reducing readmissions after total joint arthroplasty (TJA) is challenging. Pre-operative risk stratification and optimization pre surgical care may be helpful in reducing readmission rates after primary TJA. Assessment of the predictive value of individual modifiable risk factors without a tool to properly stratify patients may not be helpful to the surgical community to reduce the risk of readmission. We developed a scoring system: Readmission Risk Assessment Tool (RRAT) as part of a Perioperative Orthopaedic Surgical Home model that allows for risk stratification in patients undergoing elective primary TJA at our institution. We analyzed the relationship between the RRAT score and readmission following primary hip or knee arthroplasty. Methods. The RRAT, which is scored incrementally based on the number and severity of modifiable comorbidities was used to generate readmission scores for a cohort of 207 readmitted and 2 cohorts of 234 (random and age-matched) non-readmitted patients each. Regression analysis was performed to assess the strength of association between individual risk factors, RRAT score and readmissions. We also calculated the odds and odds ratio (OR) at each level of RRAT score to identify patients with relatively higher risk of readmission. Results. There were 207(2.08%) 30-day readmissions in 9,930 patients over a 6-year period (2008 to 2013). Surgical site infection was the most common cause of readmission (93 cases, 45%). The median RRAT scores were 3 (IQR: 1, 4) and 1 (IQR: 0, 2) for readmitted group and non-readmitted group respectively. The RRAT score was significantly associated with readmission with odds ratio between 1.5 and 1.9 under various model assumptions. A RRAT score of 3 or higher resulted in higher odds of readmission. Discussion and Conclusion. Population health management, cost-effective care and optimization of outcomes to maximize value are the new maxims for healthcare delivery in the United States. The RRAT has a significant association with readmission following joint arthroplasty and could potentially be a clinically meaningfully tool for risk mitigation

Restoring native hip biomechanics is crucial to the success of THA. This is reflected both in terms of complications after surgery such as instability, leg length inequality, pain and limp; and in terms of patient satisfaction. The challenge that remains is that of achieving optimal implant sizing and positioning so as to restore, as closely as possible, the native hip biomechanics specific to the hip joint being replaced. This would optimise function and reduce complications, particularly, instability. (Mirza et al., 2010). Ideally, this skill should also be reproducible irrespective of the surgeon's experience, volume of surgery and learning curve.

The general consensus is that the most substantial limiting factor in a THA is the surgeon's performance and as a result, human errors and unintended complications are not completely avoidable (Tarwala and Dorr, 2011). The more challenging aspects include acetabular component version, sizing and femoral component sizing, offset and position in the femoral canal. This variability has led to interest in technologies for planning THA, and technologies that help in the execution of the procedure. Advances in surgical technology have led to the development of computer navigation and robotic systems, which assist in pre-operative planning and optimise intra-operative implant positioning.

The evolution of surgical technology in lower limb arthroplasty has led to the development of computer navigation and robotics, which are designed to minimise human error and improve implant positioning compared to pre-operative templating using plain radiographs. It is now possible to use pre-operative computerised tomography (image-based navigation) and/or anatomical landmarks (non-imaged-based navigation) to create three-dimensional images of each patient's unique anatomy. These reconstructions are then used to guide bone resection, implant positioning and lower limb alignment.

The second-generation RIO Robotic Arm Interactive Orthopaedic system (MAKO Surgical) uses pre-operative computerised tomography to build a computer-aided design (CAD) model of the patient's hip. The surgeon can then plan and execute optimal sizing and positioning of the prostheses to achieve the required bone coverage, minimise bone resection, restore joint anatomy and restore lower limb biomechanics. The MAKO robotic software processes this information to calculate the volume of bone requiring resection and creates a three-dimensional haptic window for the RIO-robotic arm to resect. The RIO-robotic arm has tactile and audio feedback to resect bone to a high degree of accuracy and preserve as much bone stock as possible.

We have used this technology in the hip to accurately reproduce the anteversion, closure and center of rotation that was planned for each hip. Whilst the precise safe target varies from patient to patient, the ability to reproduce native biomechanics, to gain fixation as planned and to get almost perfect length and offset are a great advantage. Complications such as instability and leg length inequality are thus dramatically reduced.

Longevity of total hip arthroplasty (THA) is dependent upon avoiding both short- and long-term problems. One of the most common short-term / early complications of THA is instability while longer term issues of wear remain a concern. Both of these concerns appear to be related to implant position: either static or functional. While achieving “ideal” implant position in primary THA for osteoarthritis is only successful in 50% of cases (Callanan et al.), it is even more difficult in complex primary disorders such as dysplasia and post-traumatic arthritis.

Many theories exist as to why implant position and short-term complications appear to be higher in this “complex primary” cohort but certainly the ability to achieve desired implant position appears to be more challenging. The loss of usual anatomic landmarks, the presence of soft tissue contractures, and the recognition of both pelvic and femoral deformities play a role.

Enabling technologies have emerged to help in achieving improved implant position. These technologies include both navigation (both imageless and image guided) as well as the newly adopted technology of robotic assistance. Robot-assisted THA is based upon a CT scan protocol. Three-dimensional pre-operative planning on both the femoral and acetabular side can be performed. Precision guided bone preparation and exacting implant delivery is achievable using robotic technology.

Examples of use of this technology in complex primary THA will be demonstrated including planning, preparation and implantation.

As an increasing number of young, active, large patients are becoming candidates for total hip replacements, there is an increasingly urgent need to identify arthroplasties that will be durable, highly functional and amenable to possible future successful revision. In an era when cemented femoral stems were the primary implant option, the concept of a surface replacement was attractive and, perhaps, appropriate. However, cementless femoral stems of many designs now provide dependable long-term fixation and excellent, near normal function in patients of all ages, sex and level of activity.

However, a number of issues related to cementless stem fixation could be further improved: Optimization of load transfer to proximal femur to minimise fracture risk and maximise bone preservation; Elimination of proximal-distal mismatch concerns, including bowed femurs; Facilitation of femoral stem insertion, especially with MIS THA exposures; Facilitation of revision with implants capable of providing durable fixation for active patients.

The potential benefits of short stem femoral THA implants include: Ease of insertion; Reproducibility of insertion; Avoidance of issues related to proximal-distal anatomic mismatch or variations in proximal femoral diaphyseal anatomy (e.g. femoral bowing); Facilitation of MIS surgical approaches, especially anterior exposures; Optimization of proximal femoral load transfer with consequent maximization of proximal bone preservation.

The purpose of this presentation is to describe the design rationale and characteristics of short (<115mm) uncemented primary THA femoral stem, to evaluate the clinical and radiographic results of short stems and to discuss the possible drawbacks specific to the use of short stems.

As an increasing number of young, active, large patients are becoming candidates for total hip replacements, there is an increasingly urgent need to identify arthroplasties that will be durable, highly functional and amenable to possible future successful revision. In an era when cemented femoral stems were the primary implant option, the concept of a surface replacement was attractive and, perhaps, appropriate. However, cementless femoral stems of many designs now provide dependable long-term fixation and excellent, near normal function in patients of all ages, sex and level of activity.

However, a number of issues related to cementless stem fixation could be further improved: Optimisation of load transfer to proximal femur to minimise fracture risk and maximise bone preservation; Elimination of proximal-distal mismatch concerns, including bowed femurs; Facilitation of femoral stem insertion, especially with MIS THA exposures; Facilitation of revision with implants capable of providing durable fixation for active patients

The potential benefits of short stem femoral THA implants include: Ease of insertion; Reproducibility of insertion; Avoidance of issues related to proximal-distal anatomic mismatch or variations in proximal femoral diaphyseal anatomy (e.g. femoral bowing); Facilitation of MIS surgical approaches, especially anterior exposures; Optimisation of proximal femoral load transfer with consequent maximisation of proximal bone preservation.

The purpose of this presentation is to describe the design rationale and characteristics of short (< 115mm) uncemented primary THA femoral stem, to evaluate the clinical and radiographic results of short stems and to discuss the possible drawbacks specific to the use of short stems.

Introduction. We conducted a study of 312 patients undergoing primary hip and knee arthroplasty in 2005. The aim was to identify the correlation between length of stay, ASA (American society of Anaesthesiologist) grade and BMI (Body Mass Index). Method and materials. 312 patients underwent hip and knee arthroplasty in 2005. ASA grade for surgery was documented by the anaesthetist and BMI by the nurses. 67 patients had inadequate documentation. SPSS software was used for analysis. Results. Of the 245 patients; 35 had ASA grade 1, 144 had ASA grade 2, 64 had ASA grade 3 and 2 had ASA grade 4. Mean length of stay for ASA grade 1 was 6.8 days, ASA grade 2 was 9.75 days, ASA grade 3 was 12.5 days and ASA grade 4 was 13.5 days. There was significant positive correlation (p < 0.01) between the ASA grade and post-operative length of stay. BMI was graded as I (<18.5), II (18.5-24.9), III (25-29.9) and IV (>30). There was no correlation (Pearson's correlation coefficient = 0.184) between BMI and post-operative length of stay. Conclusion. As the ASA grade increases the length of stay in hospital increases. ‘Cherry picking’ of ASA grade I and II patients by the ISTC will increase the average length of stay in NHS hospitals resulting in increased cost. Length of stay on its own is not a good indicator of hospital performance

While short stem designs are not a new concept, interest has surged with increasing popularity of less invasive techniques. If the goal of the tapered stem is to load preferentially proximally, why do we need a stem at all? Perhaps the only reason to use a tapered, long stem is to prevent varus; however, studies have shown that varus malalignment of a tapered stem does not affect results. Short stems are easier to insert, especially when using an anterior approach such as the anterior supine intermuscular in which the proximal femur is elevated anteriorly from the wound during stem insertion. Femoral preparation can be accomplished with straightforward broaching of the canal, without use of reamers. Short stems are bone conserving. They violate less femoral bone stock, providing more favorable conditions should a revision be required. However, ease of insertion and bone conservation matter little if not supported by clinical results. Thus, we reviewed our early experience with 2094 patients undergoing 2457 primary THA using short, tapered titanium, porous plasma spray-coated femoral components since January 2006 at our center. The TaperLoc Microplasty stem (Biomet, Warsaw, IN) has been used in 1881 THA, and the TaperLoc Complete Microplasty stem (Biomet) in 576. Patient age averaged 63.6 years. Increased offset was used in 1990 hips (81%). The surgical approach was less invasive direct lateral (LIDL) in 1194 THA (49%), anterior supine intermuscular (ASI) in 1117 (46%), and standard direct lateral (Std) in 146 (6%). Follow-up averaged 20 months. Thirty-five stems (1.4%) have been revised: 15 for infection (12 LIDL, 3 ASI), 1 same day revision for intraoperative femoral shaft perforation (Std), 1 at 3 days for patellar dislocation (LIDL), 2 for early subsidence (1 LIDL, 1 ASI), 13 for periprosthetic femoral fracture (1 Std, 12 ASI), 2 for aseptic loosening (1 LIDL, 1 ASI), and 1 stem well fixed (ASI) removed for loose cup and unable to disarticulate trunnion.

What lessons have we learned? First, we usually require one or two diameter sizes larger with short porous tapered stem versus the standard length version of the same design. The surgeon should be aggressive with sizing, pushing to the largest size possible. Use the broach like a rasp. Drive the component in valgus during insertion. Upon seating the component, do a trial reduction using the shortest available neck length. The component will generally sit slightly prouder than the broach and may require additional effort to seat completely.

Conservation of existing bone stock, compatibility with soft-tissue sparing surgery, more physiologic loading of the proximal femur, and versatility with varying femoral anatomy make the short taper an attractive implant option. The tapered wedge short stem represents the natural evolution of joint arthroplasty to a smaller, less-invasive, and more efficient implant.

Fixation of the femoral component in total hip arthroplasty is a surgical challenge in the best of circumstances. Achieving immediate fixation without breaking the femur is a challenge, even to highly skilled and experienced arthroplasty surgeons. Surgical procedures are available that offer cosmetic benefit or a slightly quicker recovery, but accepting this compromise for fixation should be avoided.

The mechanical environment of the femoral component is challenging. The implant is exposed to offset loading in two planes, which results in substantial bending stress and rotational loads in the frontal plane as well as bending stress and torsional loads in the sagittal plane. The proximal femur is built to transmit load through the surface fibers, not the central cavity, so efforts to change it to a centrally loaded structure are fraught with difficulty. The entire structure should be used. The least reliable material is the cancellous bone in the intertrochanteric metaphysis and the most effective is the cancellous bone of the femoral neck and cortical bone of the upper diaphysis. For best fixation of the femoral component, the cortical bone of the upper metaphysis should be contacted, and the diaphyseal cortical bone actually should be grooved by the femoral stem during insertion.

Approach to the hip is important in fixation of the femoral component. Approaches that require femoral neck resection and use of a short stem are especially treacherous. The posterior approach is attractive because it encourages preservation of the femoral neck, and it provides straight access to the medullary canal of the femur while protecting the abductor muscles.

Static axial load in the extended position is most readily resisted by the femoral component. Distal cortical contact is very important to prevent toggle. Torsional loads generated from offset loading of the femoral head in flexion and with front-to-back acceleration generated loads during rapid gait are the most challenging in securing fixation of the implant. Ideal conditions include preservation of the femoral neck, engagement of a rectangular stem in a rectangular cavity, and mechanical lock into grooves in the diaphyseal cortical bone. If all these conditions are met, femoral component fixation can be achieved every time without damaging the abductor muscle group, and with minimal danger of femoral fracture.

A posterior approach with femoral neck preservation and a rectangular shaped femoral component with diaphyseal engaging stem is safe surgery and good mechanics. The anterior approach with femoral neck sacrifice and round, short stems is unsafe surgery and bad mechanics.

We compared the early complication rates of total hip (THA) and total knee (TKA) arthroplasty carried out at a regional orthopaedic hospital (AOC) and two Independent Sector Treatment Units (ISTUs) (WGH and CNH). After THA, reoperation rates were higher at CNH (9%) than AOC (0.6%) or WGH (1.4%). After TKA, reoperation rates at CNH were (8%) higher than AOC (1%) and WGH (1.9%).

5% of patients undergoing TKR at CNH underwent 2 stage revision for deep infection.

After THA, dislocation rates at CNH (6%) were higher than AOC and WGH (1.8%). Readmission from CNH (13%) was higher than AOC (1.2%) and WGH (0.6%).

Major wound problems at CNH (20%) were higher than WGH (3.8%) and AOC (0.4%).

After TKA, major wound problems were higher at CNH (19%) compared to WGH (1.9%) and AOC (1.1%). Readmission rates not requiring surgery from CNH (13%) were higher than AOC. (1.1%) and WGH (1%). AOC and WGH audited their outcomes. None were available from CNH. WGH initially missed many of their complications because they presented at base hospitals elsewhere.

ISTUs performed approximately 2/3rds of procedures for which patients had been referred from base hospitals.

At CNH, 23% were rejected on grounds of potential co-morbidity. Audit from ISTUs is inferior to NHS hospitals and the results in one of those audited significantly worse.

Patients offered surgery at ISTUs should be told that the audited outcome of the surgeon who will be treating them is not known and that, in some, results are inferior to surgery in the NHS.

Venous thromboembolism (VTE) is a serious complication after total hip and knee arthroplasty. There is still no consensus regarding the best mode of thromboprophylaxis after lower limb arthroplasty. The aim of this study was to ascertain the efficacy, safety profile and rate of adverse thromboembolic events of aspirin as extended out of hospital pharmacological anticoagulation for elective primary total hip and knee arthroplasty patients and whether these rates were comparable with published data for low molecular weight heparin (LMWH). Data was extracted from a prospective hospital acquired thromboembolism (HAT) database. The period of study was from 1st Jan 2013-31st Dec 2016 and a total of 6078 patients were treated with aspirin as extended thromboprophylaxis after primary total hip and knee arthroplasty. The primary outcome measure of deep vein thrombosis and pulmonary embolism within 90 days postoperatively was 1.11%. The secondary outcome rates of wound infection, bleeding complications, readmission rate and mortality were comparable to published results after LMWH use. The results of this study clearly show that Aspirin, as part of a multimodal thromboprophylactic regime, is an effective and safe regime in preventing VTE with respect to risk of DVT or PE when compared to LMWH. It is a cheaper alternative to LMWH and has associated potential cost savings

In the current austere financial climate within the NHS where local healthcare Trusts are reimbursed in a Payment by Results system it is important that we accurately identify the costs associated with surgical procedures.

We retrospectively reviewed data of 589 consecutive patients undergoing lower limb arthroplasty surgery and recorded their age, BMI and co-morbidities. The effect of these parameters on operative duration and length of stay (LOS) was analysed.

We demonstrate that for a 1 point increase in BMI we expect LOS to increase by a factor of 2.9% (p<0.0001) and mean theatre time to increase by 1.46 minutes (p<0.0001). We also show that for a l-year increase in age, we expect LOS to increase by a factor of 1.2% (p<0.0001).

We have calculated the extra financial costs associated with this and believe that the current OPCS coding system for obesity underestimates the financial impact of increasing BMI and age on lower limb arthroplasty Trusts are being inadequately reimbursed.

The results of this study have been used to produce a chart that allows prediction of LOS following lower limb arthroplasty based on BMI and age. We also believe that the data produced is of use in planning operating lists.

Abstract

Purpose. Transfusion rates after primary total hip has been reported up to 39.2%. The purpose of our study was to evaluate the efficacy of TXA in minimizing risk of allogeneic blood transfusion after primary total hip and hip resurfacing arthroplasty. Method. Retrospective data on a cohort of 88 patients undergoing total hip arthroplasty and 44 who undergoing hip resurfacing arthroplasty who received a single pre-operative bolus of 1g TXA was compared with a control group matched for starting haemoglobin (Hg), body mass index (BMI), age, gender, blood loss, surgical time, and surgeon. All procedures were completed at a single institution with standardized post-operative care. Endpoints included allogeneic blood transfusion rate, post operative day one Hg, and overall Hg decrease. Results. Transfusion rate among the total hip TXA group was 5.7% and among control patients 22.7% (p=0.001). Transfusion rates among resurfacing patients showed no statistical difference between the treatment group and matched controls. Mean overall haemoglobin decrease was found to be significantly lower in the TXA treatment groups for both total hip and hip resurfacing arthroplasty (p<0.0001 and p=0.01 respectively). Patients who received TXA and allogeneic blood transfusion were found to have a significantly lower pre-operative Hg versus transfusion negative TXA treated patients (113.7 g/dL and 141.5 g/dL respectively). Conclusion. We have shown TXA use in primary total hip arthroplasty significantly decreases allogeneic blood transfusion rate. TXA use in hip resurfacing arthroplasty failed to show significant difference in transfusion rate yet calculated blood loss was less. Patients presenting with low pre-operative Hb remain high risk for allogeneic blood transfusion despite TXA treatment

Given the high prevalence of psychiatric illness in the total joint arthroplasty (TJA) population, relatively little is known about how these two conditions affect each other. Therefore, the purpose of this study is to evaluate the role of major psychiatric illness on patient specific outcomes after TJA. We hypothesize that patients with major psychiatric illnesses will report inferior outcomes and have more complications after TJA compared to those without any psychiatric illness.

We matched and compared two cohorts of patients undergoing TJA from a prospectively collected database registry, which included those with and without a major psychiatric disorder. Major psychiatric disorder was identified in the registry database by determining if patients had been formally diagnosed with any of the following conditions: bipolar disorder, major personality disorder, chronic mental health diagnoses, depression, or schizophrenia. Primary outcomes of interest included patient specific outcomes measured using the WOMAC or EQ5D. Secondary outcomes included complications, infections, hospital length of stay, 30-day readmission rates and final discharge destination.

In total we included 1828 TJAs (1000 THAs, 828 TKAs). In terms of the primary outcome, both the THA experimental group (37.80 ± 17.91 vs. 40.74 ± 19.3, p=0.023) and TKA experimental group (43.38 ± 18.41 vs 45.45 ± 20.07, p=0.050) had significantly lower preoperative WOMAC scores compared to their respective control groups. At the 3-month period both the THA experimental group (76.74 ± 16.94 vs. 79.16 ± 16.19, p=0.036) and TKA experimental group (71.09 ± 18.64 vs. 75.92 ± 16.22, p=0) again had significantly lower 3-month postoperative WOMAC score. Clinical outcomes at the 1-year mark were similar for both groups in terms of WOMAC and EQ5D. Patients with psychiatric illness were more likely to have increased LOS and non-routine discharge from hospital. In the THA subset, the experimental group had an increased LOS by 1.43 days (p=0.0028), in the TKA subset, the experimental group had an increased LOS by 0.77 days (p= 0.050). In terms of non-routine discharge, the THA experimental group was discharged home 86.9% of the time compared to the control group at 91.8% (p=0.024). In the TKA subset, the experimental group was discharged home 87.6% of the time compared to the control group at 92% (p=0.022). There were no other differences between the two subsets in regards to transfusions, 30-day readmissions, infections, mechanical adverse events, and medical complications.

In conclusion, our results demonstrate that psychiatric illness can result in worse outcomes in the early perioperative period after TJA, although outcomes are equivalent 1 year postoperatively. Patients with psychiatric illness can be expected to gain significant improvements in outcome after surgery that are comparable to a baseline population without psychiatric illness. Nonetheless, patients with psychiatric illness are at increased risk of delayed discharge and non-routine discharge. As such, they may require personalized care post-operatively, and should be counseled accordingly. Based on our results, psychiatric illness should not be an impediment to proceeding with TJA.